{"id":17239,"date":"2019-09-12T14:33:24","date_gmt":"2019-09-12T12:33:24","guid":{"rendered":"https:\/\/news.embl.de\/?p=17239"},"modified":"2024-03-22T10:53:12","modified_gmt":"2024-03-22T09:53:12","slug":"b-cells-immunitherapy","status":"publish","type":"post","link":"https:\/\/www.embl.org\/news\/science\/b-cells-immunitherapy\/","title":{"rendered":"B cells linked to immunotherapy"},"content":{"rendered":"\n<p>Researchers at <a href=\"http:\/\/www.ebi.ac.uk\">EMBL\u2019s European Bioinformatics Institute (EMBL-EBI)<\/a> and the Medical University of Vienna have found evidence that B cells might play an important role in immunotherapy for melanoma. Currently, immunotherapy is primarily focused on T cells, but the results suggest that B cells could also provide an interesting research avenue.<\/p>\n\n\n\n<p>Immunotherapy is a form of cancer treatment that uses the body\u2019s own immune system to recognise and fight the disease. It comes in a variety of forms, including cancer vaccines, targeted antibodies or tumour-infecting viruses. &nbsp;Only some cancer patients currently benefit from this kind of therapy.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Immunotherapy &#8211; a game changer<\/h2>\n\n\n\n<p>In the case of melanoma, which is a particularly aggressive form of skin cancer, established immunotherapies focus on <a href=\"https:\/\/news.embl.de\/science\/1508_t-cells\/\" target=\"_blank\" rel=\"noopener noreferrer\">T cells<\/a>. T cells play an important role in controlling and shaping the immune system and they are able to directly kill cancer cells, while also recruiting other cells into the process.<\/p>\n\n\n\n<p>A recent study published in <em>Nature Communications <\/em>has shown that, alongside T cells, B cells play a critical role in triggering melanoma-associated inflammation. B cells are a type of white blood cell, which can produce antibodies along with several important messenger molecules. The researchers found that, in the case of melanoma, B cells act almost like a satnav, directing T cells to the tumour via the secretion of such distinct messenger molecules.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">A deeper understanding<\/h2>\n\n\n\n<p>\u201cImmunotherapy has transformed cancer treatment,\u201d explains Johannes Griss, Researcher at the Medical University of Vienna and EMBL-EBI. \u201cIt unleashes T cells so they can fight cancer in a more effective way. For the first time, we found that B cells also play an important part in the process and help T cells find the tumour. The role of B cells in immunotherapy is still largely unknown, but it seems they may have more impact than previously thought.\u201d<\/p>\n\n\n\n<p>During the study, the researchers observed that when B cells were depleted from melanoma patients, the number of T cells and other immune cells dramatically decreased within the tumours as well. In subsequent experiments, the researchers showed that a special subtype of B cells seems to be responsible for guiding T cells and other immune cells to the tumour.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Observing B cells<\/h2>\n\n\n\n<p>Interestingly, melanoma cells seem to force B cells to develop into this distinct B cell subtype. Most excitingly, this specific B cell subtype also increased the activating effect of current immune therapies on T cells, and higher numbers of this B cell subtype in tumours before therapy predicted that a patient would respond better to subsequent immunotherapy.<\/p>\n\n\n\n<p>\u201cFurther research is required to answer questions such as how melanoma cells modify B cells, what mechanism B cells use to support the activation of T cells, and how we can help these B cells to support current immunotherapies in cancer patients,\u201d concludes Griss.<\/p>\n\n\n\n<p>This post was originally published on <a href=\"https:\/\/www.ebi.ac.uk\/about\/news\/press-releases\/B-cells-immunotherapy\" target=\"_blank\" rel=\"canonical nofollow noopener noreferrer\" data-href=\"https:\/\/www.ebi.ac.uk\/about\/news\/press-releases\/B-cells-immunotherapy\">EMBL-EBI News.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Immunotherapy: the role of B cells<\/p>\n","protected":false},"author":47,"featured_media":17241,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2,17591],"tags":[28,38,189,36,921,49,922,1748],"embl_taxonomy":[],"class_list":["post-17239","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-science","category-science-technology","tag-bioinformatics","tag-cancer","tag-computational-biology","tag-embl-ebi","tag-immunotherapy","tag-interdisciplinary","tag-melanoma","tag-press-release"],"acf":{"article_intro":"<p>Researchers find evidence that B cells may be more important in immunotherapy than previously thought<\/p>\n","related_links":[{"link_description":"Know your cells","link_url":"https:\/\/news.embl.de\/science\/1508_t-cells\/"},{"link_description":"Prioritising cancer drug targets using CRISPR","link_url":"https:\/\/news.embl.de\/science\/prioritising-cancer-drug-targets-using-crispr\/"}],"article_sources":[{"source_description":"<p>GRISS, J., et al. (2019). B cells sustain inflammation and predict response to immune checkpoint blockade in human melanoma. <em>Nature Communications<\/em>. Published online 13 09; DOI: 10.1038\/S41467-019-12160-2<\/p>\n","source_link_url":"https:\/\/www.nature.com\/articles\/s41467-019-12160-2"}],"vf_locked":false,"featured":false,"color":"#007B53","show_featured_image":false,"in_this_article":false,"youtube_url":"","mp4_url":"","video_caption":"","translations":false,"press_contact":"EMBL-EBI Generic"},"embl_taxonomy_terms":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>B cells linked to immunotherapy | EMBL<\/title>\n<meta name=\"description\" content=\"EMBL-EBI researchers find evidence that B cells may be more important in immunotherapy than previously thought\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.embl.org\/news\/science\/b-cells-immunitherapy\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"B cells linked to immunotherapy | EMBL\" \/>\n<meta property=\"og:description\" content=\"EMBL-EBI researchers find evidence that B cells may be more important in immunotherapy than previously thought\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.embl.org\/news\/science\/b-cells-immunitherapy\/\" \/>\n<meta property=\"og:site_name\" content=\"EMBL\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/embl.org\/\" \/>\n<meta property=\"article:published_time\" content=\"2019-09-12T12:33:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-22T09:53:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2019\/09\/GRISS_Melanoma_620x425Credit_Christine_Wagner-copy-e1568291002317.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"620\" \/>\n\t<meta property=\"og:image:height\" content=\"425\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Oana Stroe\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@embl\" \/>\n<meta name=\"twitter:site\" content=\"@embl\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Oana Stroe\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.embl.org\/news\/science\/b-cells-immunitherapy\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/science\/b-cells-immunitherapy\/\"},\"author\":{\"name\":\"Oana Stroe\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/95d28f359cc138357c5dcf79319ef414\"},\"headline\":\"B cells linked to immunotherapy\",\"datePublished\":\"2019-09-12T12:33:24+00:00\",\"dateModified\":\"2024-03-22T09:53:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.embl.org\/news\/science\/b-cells-immunitherapy\/\"},\"wordCount\":482,\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/science\/b-cells-immunitherapy\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2019\/09\/GRISS_Melanoma_620x425Credit_Christine_Wagner-copy-e1568291002317.jpg\",\"keywords\":[\"bioinformatics\",\"cancer\",\"computational biology\",\"embl-ebi\",\"immunotherapy\",\"interdisciplinary\",\"melanoma\",\"press release\"],\"articleSection\":[\"Science\",\"Science &amp; Technology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.embl.org\/news\/science\/b-cells-immunitherapy\/\",\"url\":\"https:\/\/www.embl.org\/news\/science\/b-cells-immunitherapy\/\",\"name\":\"B cells linked to immunotherapy | EMBL\",\"isPartOf\":{\"@id\":\"https:\/\/www.embl.org\/news\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.embl.org\/news\/science\/b-cells-immunitherapy\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/science\/b-cells-immunitherapy\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2019\/09\/GRISS_Melanoma_620x425Credit_Christine_Wagner-copy-e1568291002317.jpg\",\"datePublished\":\"2019-09-12T12:33:24+00:00\",\"dateModified\":\"2024-03-22T09:53:12+00:00\",\"description\":\"EMBL-EBI researchers find evidence that B cells may be more important in immunotherapy than previously thought\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.embl.org\/news\/science\/b-cells-immunitherapy\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/science\/b-cells-immunitherapy\/#primaryimage\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2019\/09\/GRISS_Melanoma_620x425Credit_Christine_Wagner-copy-e1568291002317.jpg\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2019\/09\/GRISS_Melanoma_620x425Credit_Christine_Wagner-copy-e1568291002317.jpg\",\"width\":620,\"height\":425,\"caption\":\"Using multiplex-immunostaining to characterise B cells. PHOTO: Christine Wagner\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.embl.org\/news\/#website\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"name\":\"European Molecular Biology Laboratory News\",\"description\":\"News from the European Molecular Biology Laboratory\",\"publisher\":{\"@id\":\"https:\/\/www.embl.org\/news\/#organization\"},\"alternateName\":\"EMBL News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.embl.org\/news\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.embl.org\/news\/#organization\",\"name\":\"European Molecular Biology Laboratory\",\"alternateName\":\"EMBL\",\"url\":\"https:\/\/www.embl.org\/news\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"contentUrl\":\"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png\",\"width\":300,\"height\":144,\"caption\":\"European Molecular Biology Laboratory\"},\"image\":{\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/embl.org\/\",\"https:\/\/x.com\/embl\",\"https:\/\/www.instagram.com\/embl_org\/\",\"https:\/\/www.linkedin.com\/company\/15813\/\",\"https:\/\/www.youtube.com\/user\/emblmedia\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/95d28f359cc138357c5dcf79319ef414\",\"name\":\"Oana Stroe\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.embl.org\/news\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/105fb83bbeaf64062ef1f4608964e5163ac52f590628df2ffde6de9a0d85af80?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/105fb83bbeaf64062ef1f4608964e5163ac52f590628df2ffde6de9a0d85af80?s=96&d=mm&r=g\",\"caption\":\"Oana Stroe\"},\"description\":\"Oana Stroe is a PR specialist and copywriter with experience in engineering, IT and life sciences. She now collects and shares remarkable science stories.\",\"url\":\"https:\/\/www.embl.org\/news\/author\/oana-stroe-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-3\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"B cells linked to immunotherapy | EMBL","description":"EMBL-EBI researchers find evidence that B cells may be more important in immunotherapy than previously thought","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.embl.org\/news\/science\/b-cells-immunitherapy\/","og_locale":"en_US","og_type":"article","og_title":"B cells linked to immunotherapy | EMBL","og_description":"EMBL-EBI researchers find evidence that B cells may be more important in immunotherapy than previously thought","og_url":"https:\/\/www.embl.org\/news\/science\/b-cells-immunitherapy\/","og_site_name":"EMBL","article_publisher":"https:\/\/www.facebook.com\/embl.org\/","article_published_time":"2019-09-12T12:33:24+00:00","article_modified_time":"2024-03-22T09:53:12+00:00","og_image":[{"width":620,"height":425,"url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2019\/09\/GRISS_Melanoma_620x425Credit_Christine_Wagner-copy-e1568291002317.jpg","type":"image\/jpeg"}],"author":"Oana Stroe","twitter_card":"summary_large_image","twitter_creator":"@embl","twitter_site":"@embl","twitter_misc":{"Written by":"Oana Stroe","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.embl.org\/news\/science\/b-cells-immunitherapy\/#article","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/science\/b-cells-immunitherapy\/"},"author":{"name":"Oana Stroe","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/95d28f359cc138357c5dcf79319ef414"},"headline":"B cells linked to immunotherapy","datePublished":"2019-09-12T12:33:24+00:00","dateModified":"2024-03-22T09:53:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.embl.org\/news\/science\/b-cells-immunitherapy\/"},"wordCount":482,"publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"image":{"@id":"https:\/\/www.embl.org\/news\/science\/b-cells-immunitherapy\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2019\/09\/GRISS_Melanoma_620x425Credit_Christine_Wagner-copy-e1568291002317.jpg","keywords":["bioinformatics","cancer","computational biology","embl-ebi","immunotherapy","interdisciplinary","melanoma","press release"],"articleSection":["Science","Science &amp; Technology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.embl.org\/news\/science\/b-cells-immunitherapy\/","url":"https:\/\/www.embl.org\/news\/science\/b-cells-immunitherapy\/","name":"B cells linked to immunotherapy | EMBL","isPartOf":{"@id":"https:\/\/www.embl.org\/news\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.embl.org\/news\/science\/b-cells-immunitherapy\/#primaryimage"},"image":{"@id":"https:\/\/www.embl.org\/news\/science\/b-cells-immunitherapy\/#primaryimage"},"thumbnailUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2019\/09\/GRISS_Melanoma_620x425Credit_Christine_Wagner-copy-e1568291002317.jpg","datePublished":"2019-09-12T12:33:24+00:00","dateModified":"2024-03-22T09:53:12+00:00","description":"EMBL-EBI researchers find evidence that B cells may be more important in immunotherapy than previously thought","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.embl.org\/news\/science\/b-cells-immunitherapy\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/science\/b-cells-immunitherapy\/#primaryimage","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2019\/09\/GRISS_Melanoma_620x425Credit_Christine_Wagner-copy-e1568291002317.jpg","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2019\/09\/GRISS_Melanoma_620x425Credit_Christine_Wagner-copy-e1568291002317.jpg","width":620,"height":425,"caption":"Using multiplex-immunostaining to characterise B cells. PHOTO: Christine Wagner"},{"@type":"WebSite","@id":"https:\/\/www.embl.org\/news\/#website","url":"https:\/\/www.embl.org\/news\/","name":"European Molecular Biology Laboratory News","description":"News from the European Molecular Biology Laboratory","publisher":{"@id":"https:\/\/www.embl.org\/news\/#organization"},"alternateName":"EMBL News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.embl.org\/news\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.embl.org\/news\/#organization","name":"European Molecular Biology Laboratory","alternateName":"EMBL","url":"https:\/\/www.embl.org\/news\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/","url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","contentUrl":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2025\/09\/EMBL_logo_colour-1-300x144-1.png","width":300,"height":144,"caption":"European Molecular Biology Laboratory"},"image":{"@id":"https:\/\/www.embl.org\/news\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/embl.org\/","https:\/\/x.com\/embl","https:\/\/www.instagram.com\/embl_org\/","https:\/\/www.linkedin.com\/company\/15813\/","https:\/\/www.youtube.com\/user\/emblmedia\/"]},{"@type":"Person","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/95d28f359cc138357c5dcf79319ef414","name":"Oana Stroe","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.embl.org\/news\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/105fb83bbeaf64062ef1f4608964e5163ac52f590628df2ffde6de9a0d85af80?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/105fb83bbeaf64062ef1f4608964e5163ac52f590628df2ffde6de9a0d85af80?s=96&d=mm&r=g","caption":"Oana Stroe"},"description":"Oana Stroe is a PR specialist and copywriter with experience in engineering, IT and life sciences. She now collects and shares remarkable science stories.","url":"https:\/\/www.embl.org\/news\/author\/oana-stroe-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-2-3\/"}]}},"field_target_display":"embl","field_article_language":{"value":"english","label":"English"},"fimg_url":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2019\/09\/GRISS_Melanoma_620x425Credit_Christine_Wagner-copy-e1568291002317.jpg","featured_image_src":"https:\/\/www.embl.org\/news\/wp-content\/uploads\/2019\/09\/GRISS_Melanoma_620x425Credit_Christine_Wagner-copy-e1568291002317.jpg","_links":{"self":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/17239","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/users\/47"}],"replies":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/comments?post=17239"}],"version-history":[{"count":8,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/17239\/revisions"}],"predecessor-version":[{"id":24630,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/posts\/17239\/revisions\/24630"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media\/17241"}],"wp:attachment":[{"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/media?parent=17239"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/categories?post=17239"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/tags?post=17239"},{"taxonomy":"embl_taxonomy","embeddable":true,"href":"https:\/\/www.embl.org\/news\/wp-json\/wp\/v2\/embl_taxonomy?post=17239"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}